Table 1 Mixed linear model analysis solution for fixed effects on pain intensity
From: Nitric oxide is negatively correlated to pain during acute inflammation
Effect | TTT | Estimate | Error | DF | t Value | Pr > |t| |
|---|---|---|---|---|---|---|
Intercept | Â | 3.5634 | 0.4854 | 25 | 7.34 | < .0001 |
T1 | Â | -2.3715 | 0.2329 | 201 | -10.18 | < .0001 |
T2 | Â | -2.3553 | 0.2252 | 201 | -10.46 | < .0001 |
T3 | Â | -1.9908 | 0.2243 | 201 | -8.88 | < .0001 |
T4 | Â | -1.3578 | 0.2276 | 201 | -5.97 | < .0001 |
T5 | Â | -1.0752 | 0.2217 | 201 | -4.85 | < .0001 |
T6 | Â | -0.6795 | 0.2174 | 201 | -3.12 | 0.0020 |
T7 | Â | -0.2980 | 0.2161 | 201 | -1.38 | 0.1696 |
T8 | Â | -0.1076 | 0.2162 | 201 | -0.50 | 0.6193 |
T9 | Â | 0 | Â | Â | Â | Â |
Treatment | Placebo | 0 | Â | Â | Â | Â |
Treatment | Ketorolac | 0.3034 | 0.5885 | 201 | -0.52 | 0.6067 |
NO | Â | -0.6782 | 0.2099 | 201 | -3.23 | 0.0014 |
NO * treatment | Placebo | 0 | Â | Â | Â | Â |
NO * treatment | Ketorolac | -0.8911 | 0.2632 | 201 | 3.39 | 0.0009 |